A Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid Leukemia

NCT04471064 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: XY0206

Sponsor

Shijiazhuang Yiling Pharmaceutical Co. Ltd

Collaborators

[object Object]